Abstract
Glaucoma continues to be one of the leading causes of vision loss worldwide. In 2020, an estimated 4.5 million persons will suffer moderate to severe vision impairment and an estimated 3.2 million blind will be blind due to this ophthalmic condition.1
Original language | English |
---|---|
Pages (from-to) | 877-878 |
Number of pages | 2 |
Journal | Clinical and Experimental Ophthlamology |
Volume | 48 |
Issue number | 7 |
DOIs | |
Publication status | Published - Sept 2020 |
Keywords
- Editorial
- Glaucoma
- vision loss
- intraocular pressure
- retinal ganglion cells
- neuroprotective approaches
- antioxidant vitamins